FDA approves Novartis combo therapy for aggressive type of thyroid cancer - Life Tips

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Sunday, May 6, 2018

FDA approves Novartis combo therapy for aggressive type of thyroid cancer

The US Food and Drug Administration on Friday approved Novartis AG’s combination therapy to treat an aggressive type of thyroid cancer.The therapy, which uses Novartis’ Tafinlar and Mekinist, was approved to treat anaplastic thyroid cancer that...

from GEO TV - Pakistan https://ift.tt/2FNgRiF
via IFTTT

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages